Description
GLUCOWELL 50 mg Tablets (28’s)
GLUCOWELL 50 mg Tablets contain Sitagliptin, a DPP-4 (dipeptidyl peptidase-4) inhibitor used for the treatment of type 2 diabetes mellitus. Sitagliptin works by increasing the levels of incretin hormones, which help regulate blood glucose by increasing insulin release and decreasing glucagon levels in a glucose-dependent manner.
GLUCOWELL is typically prescribed as monotherapy for patients who cannot tolerate metformin, or as part of combination therapy with other antidiabetic agents when blood sugar control is not adequately achieved. It is well-tolerated, weight-neutral, and has a low risk of hypoglycemia when not combined with sulfonylureas or insulin.
The 28-tablet pack is convenient for a one-month supply when taken once daily, improving consistency in diabetes management.
Key Features:
-
Contains 50 mg Sitagliptin per tablet
-
DPP-4 inhibitor for effective blood glucose control in type 2 diabetes
-
Enhances insulin secretion and reduces glucagon levels in a glucose-dependent manner
-
Low risk of hypoglycemia when used alone
-
Weight-neutral profile
-
Can be used as monotherapy or in combination with other antidiabetic agents
-
28-tablet pack for monthly adherence
Use only as prescribed by a healthcare professional, along with appropriate diet and lifestyle changes.
Reviews
There are no reviews yet.